Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VaxInnate logo — Advancing the future of healthcare with innovative vaccines...

VaxInnate

Advancing the future of healthcare with innovative vaccines for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus since 2002.

Founded 2002 Series Unknown Total: $132.46M Biotechnology, Health Care

General Information

Company Name VaxInnate
Founded Year 2002
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when VaxInnate moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VaxInnate

VaxInnate is a biotechnology company that has been advancing the future of healthcare since 2002. The company is dedicated to creating innovative vaccines for various illnesses, including flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. Based in Cranbury, New Jersey, VaxInnate focuses on healthcare, health diagnostics, and biotechnology. The company received a significant $3.25M Venture Round investment on 28 September 2015.

Taxonomy: Vaccine development, Flu vaccine, Malaria vaccine, Dengue vaccine, Papillomavirus vaccine, Respiratory syncytial virus vaccine, Health diagnostics, Innovative healthcare solutions, Bioinnovation, New Jersey-based company, Vaccine technology, Disease prevention, Immunization research

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 28 Sep 2015
Venture Round •••••• 1
Investor
02 Oct 2014
Grant •••••• - 28 Jan 2014
Grant •••••• 1 •••• •••• 04 Apr 2013
Debt Financing •••••• - 24 Feb 2012

View All 9 Funding Rounds

VaxInnate Alternatives & Competitors

VaxInnate vs
Fluart Innovative Vaccines
Fluart Innovative Vaccines Hungary

Pharmaceutical firm with 33+ years' expertise in human vaccine production, research, development, an...

30 employees
Manufacturing, Pharmaceutical
VaxInnate vs
GeoVax Labs, Inc.
GeoVax Labs, Inc. United States

Currently in Multiple Phase 2 Vaccine Trials

27 employees
VaxInnate vs
MEDIGEN, INC.
MEDIGEN, INC. United States

Vaccines for Life

8 employees
Biotechnology, Health Care

FAQ About VaxInnate

Advancing the future of healthcare with innovative vaccines for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus since 2002.
VaxInnate was founded in 2002.
VaxInnate operates in the following industries: Biotechnology, Health Care.
VaxInnate has completed 9 funding rounds, raising a total of $132.46M. The latest funding stage is Series Unknown.
Top alternatives and competitors to VaxInnate include Fluart Innovative Vaccines, GeoVax Labs, Inc., MEDIGEN, INC., Pegasus Biotech Inc., Rokote Laboratories Finland Oy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VaxInnate and Fluart Innovative Vaccines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VaxInnate and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy